Maria Skamagas, MD
- ASSISTANT PROFESSOR | Medicine, Endocrinology, Diabetes and Bone Disease
- Endocrine, Diabetes and Bone Diseases
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai Queens
Dr. Maria Skamagas completed her residency training in Internal Medicine and fellowship training in Endocrinology at the Mount Sinai Hospital. She was Chief Fellow during her Endocrinology training. Dr. Skamagas is currently an Assistant Professor in the Division of Endocrinology, Diabetes, and Bone Disease. Her clinical interests include type 1 and type 2 diabetes mellitus, female hormone disorders (irregular menses, polycystic ovary syndrome, menopause), adrenal insufficiency, adrenal tumors, pituitary tumors, and bone disease.
Dr. Skamagas has expertise in managing complex patients with diabetes and endocrine disorders. Dr. Skamagas is an astute clinician who uses her understanding of endocrine pathophysiology to individualize medical therapy and dietary advice to each patient. She is actively involved in teaching medical students, housestaff, and physicians. She is also certified in clinical densitometry (bone density studies) in the evaluation of osteoporosis.
Diabetes & Metabolism
- Addison's Disease
- Pituitary Adenoma
- Polycystic Ovary Syndrome
- Type 1 Diabetes
- Type 2 Diabetes
MD, SUNY at Stony Brook School of Medicine
Residency, Internal Medicine
Mount Sinai Hospital
Mount Sinai Hospital
Skamagas M, Geer E. Autoimmune Hyperthyroidism due to Secondary Adrenal Insufficiency: Resolution with Glucocorticoids. Endocrine Practice 2010 September;: 1-18.
Skamagas M. Case Study: Diabetes and Oral Diseases. Insulin 2010; 5.
Skamagas M, Breen T, LeRoith D. Update on Diabetes Mellitus: Prevention, Treatment, and Association with Oral Diseases. Oral Diseases 2008; 14: 105-114.
Weight Management in Type 2 Diabetes. Mount Sinai Journal of Medicine.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Skamagas during 2017 and/or 2018. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Scientific Advisory Board:
- Genzyme Corporation
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.